These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10479134)

  • 1. Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.
    Wright PF; Lambert JS; Gorse GJ; Hsieh RH; McElrath MJ; Weinhold K; Wara DW; Anderson EL; Keefer MC; Jackson S; Wagner LJ; Francis DP; Fast PE; McNamara J
    J Infect Dis; 1999 Oct; 180(4):1080-8. PubMed ID: 10479134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.
    Cunningham CK; Wara DW; Kang M; Fenton T; Hawkins E; McNamara J; Mofenson L; Duliege AM; Francis D; McFarland EJ; Borkowsky W;
    Clin Infect Dis; 2001 Mar; 32(5):801-7. PubMed ID: 11229849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers.
    McFarland EJ; Johnson DC; Muresan P; Fenton T; Tomaras GD; McNamara J; Read JS; Douglas SD; Deville J; Gurwith M; Gurunathan S; Lambert JS
    AIDS; 2006 Jul; 20(11):1481-9. PubMed ID: 16847402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gpl60 vaccine among adults with advanced HIV infection. Massachusetts gp160 Working Group.
    DeMaria A; Kunches L; Mayer K; Cohen C; Epstein P; Werner B; Day J; DeCristofaro J; Landers S; Tang Y; Coady W
    J Hum Virol; 2000; 3(4):182-92. PubMed ID: 10990166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine.
    McFarland EJ; Borkowsky W; Fenton T; Wara D; McNamara J; Samson P; Kang M; Mofenson L; Cunningham C; Duliege AM; Sinangil F; Spector SA; Jimenez E; Bryson Y; Burchett S; Frenkel LM; Yogev R; Gigliotti F; Luzuriaga K; Livingston RA;
    J Infect Dis; 2001 Nov; 184(10):1331-5. PubMed ID: 11679925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
    Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
    Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus (HIV) type 1 antibodies in perinatal HIV-1 infection: association with human HIV-1 transmission, infection, and disease progression. For the Women and Infants Transmission Study.
    Pitt J; Henrard D; FitzGerald G; Mofenson L; Lew J; Hillyer G; Mendez H; Cooper E; Hanson C; Rich KC
    J Infect Dis; 2000 Oct; 182(4):1243-6. PubMed ID: 10979926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.
    Johnson DC; McFarland EJ; Muresan P; Fenton T; McNamara J; Read JS; Hawkins E; Bouquin PL; Estep SG; Tomaras GD; Vincent CA; Rathore M; Melvin AJ; Gurunathan S; Lambert J
    J Infect Dis; 2005 Dec; 192(12):2129-33. PubMed ID: 16288378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up.
    Carneiro M; Sanchéz A; Maneiro P; Angelosante W; Pérez C; Valleé M
    Placenta; 2001 Apr; 22 Suppl A():S13-8. PubMed ID: 11312622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q
    Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of vertical transmission of HIV in Denmark].
    Rasmussen MB; Rasmussen JB; Nielsen VR; Herlin T; Fisker N; Hornstrup MK; Vinter H; Olofsson M; Weis NM
    Ugeskr Laeger; 2008 Aug; 170(34):2567-70. PubMed ID: 18761841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
    Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
    Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials.
    Hompe ED; Mangold JF; Kumar A; Eudailey JA; McGuire E; Haynes BF; Moody MA; Wright PF; Fouda GG; Giorgi EE; Gao F; Permar SR
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32493720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: CD4 counts of HIV-infected pregnant women and their infected children--implications for PMTCT and treatment programmes.
    Lebon A; Bland RM; Rollins NC; Coutsoudis A; Coovadia H; Newell ML
    Trop Med Int Health; 2007 Dec; 12(12):1472-4. PubMed ID: 18076554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
    St John AM; Kumar A; Cave C
    Pediatr Infect Dis J; 2003 May; 22(5):422-6. PubMed ID: 12792382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10-secreting T cells from HIV-infected pregnant women downregulate HIV-1 replication: effect enhanced by antiretroviral treatment.
    Bento CA; Hygino J; Andrade RM; Saramago CS; Silva RG; Silva AA; Linhares UC; Brindeiro R; Tanuri A; Rosenzwajg M; Klatzmann D; Andrade AF
    AIDS; 2009 Jan; 23(1):9-18. PubMed ID: 19050381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.